Edgewise Therapeutics (EWTX)
(Delayed Data from NSDQ)
$17.05 USD
-0.04 (-0.23%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $17.06 +0.01 (0.06%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.37 |
EPS Last Quarter | -0.34 |
Last EPS Surprise | 5.56% |
ABR | 1.17 |
Earnings ESP
|
-3.50% |
---|---|
Current Year | -1.46 |
Next Year | -1.82 |
EPS (TTM) | -1.55 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.37 | -0.39 | -1.46 | -1.82 |
# of Estimates | 5 | 5 | 5 | 5 |
Most Recent Consensus | -0.39 | -0.40 | -1.46 | -1.81 |
High Estimate | -0.32 | -0.33 | -1.37 | -1.41 |
Low Estimate | -0.42 | -0.44 | -1.54 | -2.04 |
Year ago EPS | -0.41 | -0.47 | -1.57 | -1.46 |
Year over Year Growth Est. | 9.76% | 17.02% | 7.01% | -24.38% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 2 | 2 | 3 | 2 |
Up Last 30 Days | 2 | 2 | 3 | 2 |
Up Last 60 Days | 2 | 2 | 3 | 2 |
Down Last 7 Days | 2 | 1 | 1 | 2 |
Down Last 30 Days | 2 | 1 | 1 | 2 |
Down Last 60 Days | 2 | 1 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.37 | -0.39 | -1.46 | -1.82 |
7 Days Ago | -0.37 | -0.39 | -1.59 | -1.98 |
30 Days Ago | -0.37 | -0.39 | -1.59 | -1.98 |
60 Days Ago | -0.37 | -0.39 | -1.59 | -1.98 |
90 Days Ago | -0.38 | -0.40 | -1.65 | -2.04 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.39 | -0.40 | -1.47 | -1.92 |
Zacks Consensus Estimate | -0.37 | -0.39 | -1.46 | -1.82 |
Earnings ESP | -3.50% | -3.63% | -0.34% | -5.59% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.34 | -0.33 | -0.47 | -0.41 | NA |
Estimate | -0.36 | -0.39 | -0.44 | -0.40 | NA |
Difference | 0.02 | 0.06 | -0.03 | -0.01 | 0.01 |
Surprise | 5.56% | 15.38% | -6.82% | -2.50% | 2.91% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more